Successes and challenges in modeling heterogeneous BRAFV600E mutated central nervous system neoplasms

Abstract excerpt

Central nervous system (CNS) neoplasms are difficult to treat due to their sensitive location. Over the past two decades, the availability of patient tumor materials facilitated large scale genomic and epigenomic profiling studies, which have resulted in detailed insights into the molecular underpinnings of CNS tumorigenesis. Based on results from these studies, CNS tumors have high molecular and cellular...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Glioma Diagnosis and Treatment
• Share to Neuroblastoma Research and Treatments
• Share to Protein Degradation and Inhibitors